In vitro activities of nontraditional antimicrobials against multiresistant Acinetobacter baumannii strains isolated in an intensive care unit outbreak
Appleman MD, Belzberg H, Citron DM, Heseltine PNR, Yellin AE, Murray J and Berne TV. In vitro activities of nontraditional antimicrobials against multiresistant Acinetobacter baumannii strains isolated in an intensive care unit outbreak. Antimicrobial Agents and Chemotherapy 2000; 44: 1035.
Efficacy of rifampicin, imipenem and sulbactam in monotherapy and combination, in the experimental pneumonia caused by panresistant Acinetobacter baumannii
Pachón-Ibáñez ME, Docobo-Pérez F, Jiménez-Mejías ME, Pichardo C, García-Curiel A and Pachón J. Efficacy of rifampicin, imipenem and sulbactam in monotherapy and combination, in the experimental pneumonia caused by panresistant Acinetobacter baumannii. Clinical Microbiology of Infection 2005; 11: 577.
Validation of high-performance liquid chromatography methods for pharmaceutical analysis. Understanding the differences and similarities between validation requirements of the US Food and Drug Administration, the US Pharmacopeia and the International conference on Harmonization
Shabir GA. Validation of high-performance liquid chromatography methods for pharmaceutical analysis. Understanding the differences and similarities between validation requirements of the US Food and Drug Administration, the US Pharmacopeia and the International conference on Harmonization. Journal of Chromatography A 2003; 987: 57.
Evaluation of the activities of two-drug combinations or rifampicin, polymixin B and ampicillin/sulbactam against Acinetobacter baumannii
Tascini C, Menichetti F, Bozza S, Favero A and Bistoni F. Evaluation of the activities of two-drug combinations or rifampicin, polymixin B and ampicillin/sulbactam against Acinetobacter baumannii. Journal of Antimicrobial Chemotherapy 1998; 42: 270.
Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii
Urban C, Segal-Maurer S, Rahal JJ. Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii. Clinical Infectious Disease 2003; 36: 1268.
In vivo efficacies of combinations of β-lactams, β-lactamase inhibitors and rifampicin against Acinetobacter baumannii in a mouse pneumonia model
Wolff M, Joly-Guillou M, Farinotti R and Carbon C. In vivo efficacies of combinations of β-lactams, β-lactamase inhibitors and rifampicin against Acinetobacter baumannii in a mouse pneumonia model. Antimicrobial Agents and Chemotherapy 1999; 43: 1406.